Global Gastric Cancer Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Gastric cancer drugs are used to treat malignancies, or cancerous growths.
SCOPE OF THE REPORT:
This report studies the Gastric Cancer Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastric Cancer Drugs market by product type and applications/end industries.
The APAC region to account for the highest market share during the forecast period. Much of this region?s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive market share of nearly 45% during the forecast period.
The world gastric cancer drugs market could be classified into seven types: doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab.
The global Gastric Cancer Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastric Cancer Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
SCOPE OF THE REPORT:
This report studies the Gastric Cancer Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastric Cancer Drugs market by product type and applications/end industries.
The APAC region to account for the highest market share during the forecast period. Much of this region?s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive market share of nearly 45% during the forecast period.
The world gastric cancer drugs market could be classified into seven types: doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab.
The global Gastric Cancer Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastric Cancer Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Sanofi
- Eli Lilly
- F. Hoffmann-La Roche
- Otsuka Pharmaceutical
- Novartis
- Amgen
- Merck
- AstraZeneca
- Boehringer Ingelheim
- Daiichi-Sankyo
- Bayer HealthCare
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Doxorubicin Hydrochloride
- Sunitinib
- Docetaxel
- Mitomycin
- Fluorouracil
- Imatinib
- Trastuzumab
- Hospitals
- Clinics
- Other
1 GASTRIC CANCER DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Gastric Cancer Drugs
1.2 Classification of Gastric Cancer Drugs by Types
1.2.1 Global Gastric Cancer Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Gastric Cancer Drugs Revenue Market Share by Types in 2017
1.2.3 Doxorubicin Hydrochloride
1.2.4 Sunitinib
1.2.5 Docetaxel
1.2.6 Mitomycin
1.2.7 Fluorouracil
1.2.8 Imatinib
1.2.9 Trastuzumab
1.3 Global Gastric Cancer Drugs Market by Application
1.3.1 Global Gastric Cancer Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Gastric Cancer Drugs Market by Regions
1.4.1 Global Gastric Cancer Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Gastric Cancer Drugs (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Gastric Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Gastric Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Gastric Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Otsuka Pharmaceutical
2.4.1 Business Overview
2.4.2 Gastric Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Otsuka Pharmaceutical Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Gastric Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amgen
2.6.1 Business Overview
2.6.2 Gastric Cancer Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Gastric Cancer Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 Gastric Cancer Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AstraZeneca Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Gastric Cancer Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Daiichi-Sankyo
2.10.1 Business Overview
2.10.2 Gastric Cancer Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Daiichi-Sankyo Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bayer HealthCare
2.11.1 Business Overview
2.11.2 Gastric Cancer Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bayer HealthCare Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL GASTRIC CANCER DRUGS MARKET COMPETITION, BY PLAYERS
3.1 Global Gastric Cancer Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Gastric Cancer Drugs Players Market Share
3.2.2 Top 10 Gastric Cancer Drugs Players Market Share
3.3 Market Competition Trend
4 GLOBAL GASTRIC CANCER DRUGS MARKET SIZE BY REGIONS
4.1 Global Gastric Cancer Drugs Revenue and Market Share by Regions
4.2 North America Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA GASTRIC CANCER DRUGS REVENUE BY COUNTRIES
5.1 North America Gastric Cancer Drugs Revenue by Countries (2013-2018)
5.2 USA Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6 EUROPE GASTRIC CANCER DRUGS REVENUE BY COUNTRIES
6.1 Europe Gastric Cancer Drugs Revenue by Countries (2013-2018)
6.2 Germany Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6.4 France Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC GASTRIC CANCER DRUGS REVENUE BY COUNTRIES
7.1 Asia-Pacific Gastric Cancer Drugs Revenue by Countries (2013-2018)
7.2 China Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7.5 India Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA GASTRIC CANCER DRUGS REVENUE BY COUNTRIES
8.1 South America Gastric Cancer Drugs Revenue by Countries (2013-2018)
8.2 Brazil Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE GASTRIC CANCER DRUGS BY COUNTRIES
9.1 Middle East and Africa Gastric Cancer Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
10 GLOBAL GASTRIC CANCER DRUGS MARKET SEGMENT BY TYPE
10.1 Global Gastric Cancer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Gastric Cancer Drugs Market Forecast by Type (2018-2023)
10.3 Doxorubicin Hydrochloride Revenue Growth Rate (2013-2023)
10.4 Sunitinib Revenue Growth Rate (2013-2023)
10.5 Docetaxel Revenue Growth Rate (2013-2023)
10.6 Mitomycin Revenue Growth Rate (2013-2023)
10.7 Fluorouracil Revenue Growth Rate (2013-2023)
10.8 Imatinib Revenue Growth Rate (2013-2023)
10.9 Trastuzumab Revenue Growth Rate (2013-2023)
11 GLOBAL GASTRIC CANCER DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Gastric Cancer Drugs Revenue Market Share by Application (2013-2018)
11.2 Gastric Cancer Drugs Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 GLOBAL GASTRIC CANCER DRUGS MARKET SIZE FORECAST (2018-2023)
12.1 Global Gastric Cancer Drugs Market Size Forecast (2018-2023)
12.2 Global Gastric Cancer Drugs Market Forecast by Regions (2018-2023)
12.3 North America Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
12.6 South America Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Gastric Cancer Drugs
1.2 Classification of Gastric Cancer Drugs by Types
1.2.1 Global Gastric Cancer Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Gastric Cancer Drugs Revenue Market Share by Types in 2017
1.2.3 Doxorubicin Hydrochloride
1.2.4 Sunitinib
1.2.5 Docetaxel
1.2.6 Mitomycin
1.2.7 Fluorouracil
1.2.8 Imatinib
1.2.9 Trastuzumab
1.3 Global Gastric Cancer Drugs Market by Application
1.3.1 Global Gastric Cancer Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Gastric Cancer Drugs Market by Regions
1.4.1 Global Gastric Cancer Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastric Cancer Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Gastric Cancer Drugs (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Gastric Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Gastric Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Gastric Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Otsuka Pharmaceutical
2.4.1 Business Overview
2.4.2 Gastric Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Otsuka Pharmaceutical Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Gastric Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amgen
2.6.1 Business Overview
2.6.2 Gastric Cancer Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Gastric Cancer Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 Gastric Cancer Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AstraZeneca Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Gastric Cancer Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Daiichi-Sankyo
2.10.1 Business Overview
2.10.2 Gastric Cancer Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Daiichi-Sankyo Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bayer HealthCare
2.11.1 Business Overview
2.11.2 Gastric Cancer Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bayer HealthCare Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL GASTRIC CANCER DRUGS MARKET COMPETITION, BY PLAYERS
3.1 Global Gastric Cancer Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Gastric Cancer Drugs Players Market Share
3.2.2 Top 10 Gastric Cancer Drugs Players Market Share
3.3 Market Competition Trend
4 GLOBAL GASTRIC CANCER DRUGS MARKET SIZE BY REGIONS
4.1 Global Gastric Cancer Drugs Revenue and Market Share by Regions
4.2 North America Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA GASTRIC CANCER DRUGS REVENUE BY COUNTRIES
5.1 North America Gastric Cancer Drugs Revenue by Countries (2013-2018)
5.2 USA Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6 EUROPE GASTRIC CANCER DRUGS REVENUE BY COUNTRIES
6.1 Europe Gastric Cancer Drugs Revenue by Countries (2013-2018)
6.2 Germany Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6.4 France Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC GASTRIC CANCER DRUGS REVENUE BY COUNTRIES
7.1 Asia-Pacific Gastric Cancer Drugs Revenue by Countries (2013-2018)
7.2 China Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7.5 India Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA GASTRIC CANCER DRUGS REVENUE BY COUNTRIES
8.1 South America Gastric Cancer Drugs Revenue by Countries (2013-2018)
8.2 Brazil Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE GASTRIC CANCER DRUGS BY COUNTRIES
9.1 Middle East and Africa Gastric Cancer Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
10 GLOBAL GASTRIC CANCER DRUGS MARKET SEGMENT BY TYPE
10.1 Global Gastric Cancer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Gastric Cancer Drugs Market Forecast by Type (2018-2023)
10.3 Doxorubicin Hydrochloride Revenue Growth Rate (2013-2023)
10.4 Sunitinib Revenue Growth Rate (2013-2023)
10.5 Docetaxel Revenue Growth Rate (2013-2023)
10.6 Mitomycin Revenue Growth Rate (2013-2023)
10.7 Fluorouracil Revenue Growth Rate (2013-2023)
10.8 Imatinib Revenue Growth Rate (2013-2023)
10.9 Trastuzumab Revenue Growth Rate (2013-2023)
11 GLOBAL GASTRIC CANCER DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Gastric Cancer Drugs Revenue Market Share by Application (2013-2018)
11.2 Gastric Cancer Drugs Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 GLOBAL GASTRIC CANCER DRUGS MARKET SIZE FORECAST (2018-2023)
12.1 Global Gastric Cancer Drugs Market Size Forecast (2018-2023)
12.2 Global Gastric Cancer Drugs Market Forecast by Regions (2018-2023)
12.3 North America Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
12.6 South America Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Gastric Cancer Drugs Picture
Table Product Specifications of Gastric Cancer Drugs
Table Global Gastric Cancer Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Gastric Cancer Drugs Revenue Market Share by Types in 2017
Figure Doxorubicin Hydrochloride Picture
Figure Sunitinib Picture
Figure Docetaxel Picture
Figure Mitomycin Picture
Figure Fluorouracil Picture
Figure Imatinib Picture
Figure Trastuzumab Picture
Table Global Gastric Cancer Drugs Revenue (Million USD) by Application (2013-2023)
Figure Gastric Cancer Drugs Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Table Global Market Gastric Cancer Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Gastric Cancer Drugs Type and Applications
Table Sanofi Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Gastric Cancer Drugs Type and Applications
Table Eli Lilly Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Gastric Cancer Drugs Type and Applications
Table F. Hoffmann-La Roche Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Otsuka Pharmaceutical Gastric Cancer Drugs Type and Applications
Table Otsuka Pharmaceutical Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gastric Cancer Drugs Type and Applications
Table Novartis Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Gastric Cancer Drugs Type and Applications
Table Amgen Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Gastric Cancer Drugs Type and Applications
Table Merck Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gastric Cancer Drugs Type and Applications
Table AstraZeneca Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Gastric Cancer Drugs Type and Applications
Table Boehringer Ingelheim Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi-Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi-Sankyo Gastric Cancer Drugs Type and Applications
Table Daiichi-Sankyo Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table Bayer HealthCare Gastric Cancer Drugs Type and Applications
Table Bayer HealthCare Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Gastric Cancer Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Gastric Cancer Drugs Revenue Share by Players (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Players in 2016
Figure Global Gastric Cancer Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Gastric Cancer Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Gastric Cancer Drugs Revenue Market Share in 2017
Figure Global Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Gastric Cancer Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Gastric Cancer Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Market Share by Regions in 2017
Figure North America Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure South America Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table North America Gastric Cancer Drugs Revenue by Countries (2013-2018)
Table North America Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure USA Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Europe Gastric Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure Germany Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure UK Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure France Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Gastric Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure China Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure India Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table South America Gastric Cancer Drugs Revenue by Countries (2013-2018)
Table South America Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure Brazil Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Gastric Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Global Gastric Cancer Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Gastric Cancer Drugs Revenue Share by Type (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Type (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Type in 2017
Table Global Gastric Cancer Drugs Revenue Forecast by Type (2018-2023)
Figure Global Gastric Cancer Drugs Market Share Forecast by Type (2018-2023)
Figure Global Doxorubicin Hydrochloride Revenue Growth Rate (2013-2018)
Figure Global Sunitinib Revenue Growth Rate (2013-2018)
Figure Global Docetaxel Revenue Growth Rate (2013-2018)
Figure Global Mitomycin Revenue Growth Rate (2013-2018)
Figure Global Fluorouracil Revenue Growth Rate (2013-2018)
Figure Global Imatinib Revenue Growth Rate (2013-2018)
Figure Global Trastuzumab Revenue Growth Rate (2013-2018)
Table Global Gastric Cancer Drugs Revenue by Application (2013-2018)
Table Global Gastric Cancer Drugs Revenue Share by Application (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Application (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Application in 2017
Table Global Gastric Cancer Drugs Revenue Forecast by Application (2018-2023)
Figure Global Gastric Cancer Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Gastric Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Gastric Cancer Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Gastric Cancer Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Europe Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure South America Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Gastric Cancer Drugs Picture
Table Product Specifications of Gastric Cancer Drugs
Table Global Gastric Cancer Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Gastric Cancer Drugs Revenue Market Share by Types in 2017
Figure Doxorubicin Hydrochloride Picture
Figure Sunitinib Picture
Figure Docetaxel Picture
Figure Mitomycin Picture
Figure Fluorouracil Picture
Figure Imatinib Picture
Figure Trastuzumab Picture
Table Global Gastric Cancer Drugs Revenue (Million USD) by Application (2013-2023)
Figure Gastric Cancer Drugs Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Table Global Market Gastric Cancer Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Gastric Cancer Drugs Type and Applications
Table Sanofi Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Gastric Cancer Drugs Type and Applications
Table Eli Lilly Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Gastric Cancer Drugs Type and Applications
Table F. Hoffmann-La Roche Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Otsuka Pharmaceutical Gastric Cancer Drugs Type and Applications
Table Otsuka Pharmaceutical Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gastric Cancer Drugs Type and Applications
Table Novartis Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Gastric Cancer Drugs Type and Applications
Table Amgen Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Gastric Cancer Drugs Type and Applications
Table Merck Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gastric Cancer Drugs Type and Applications
Table AstraZeneca Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Gastric Cancer Drugs Type and Applications
Table Boehringer Ingelheim Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi-Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi-Sankyo Gastric Cancer Drugs Type and Applications
Table Daiichi-Sankyo Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table Bayer HealthCare Gastric Cancer Drugs Type and Applications
Table Bayer HealthCare Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Gastric Cancer Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Gastric Cancer Drugs Revenue Share by Players (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Players in 2016
Figure Global Gastric Cancer Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Gastric Cancer Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Gastric Cancer Drugs Revenue Market Share in 2017
Figure Global Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Gastric Cancer Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Gastric Cancer Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Market Share by Regions in 2017
Figure North America Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure South America Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table North America Gastric Cancer Drugs Revenue by Countries (2013-2018)
Table North America Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure USA Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Europe Gastric Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure Germany Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure UK Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure France Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Gastric Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure China Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure India Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table South America Gastric Cancer Drugs Revenue by Countries (2013-2018)
Table South America Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure Brazil Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Gastric Cancer Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Gastric Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Global Gastric Cancer Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Gastric Cancer Drugs Revenue Share by Type (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Type (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Type in 2017
Table Global Gastric Cancer Drugs Revenue Forecast by Type (2018-2023)
Figure Global Gastric Cancer Drugs Market Share Forecast by Type (2018-2023)
Figure Global Doxorubicin Hydrochloride Revenue Growth Rate (2013-2018)
Figure Global Sunitinib Revenue Growth Rate (2013-2018)
Figure Global Docetaxel Revenue Growth Rate (2013-2018)
Figure Global Mitomycin Revenue Growth Rate (2013-2018)
Figure Global Fluorouracil Revenue Growth Rate (2013-2018)
Figure Global Imatinib Revenue Growth Rate (2013-2018)
Figure Global Trastuzumab Revenue Growth Rate (2013-2018)
Table Global Gastric Cancer Drugs Revenue by Application (2013-2018)
Table Global Gastric Cancer Drugs Revenue Share by Application (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Application (2013-2018)
Figure Global Gastric Cancer Drugs Revenue Share by Application in 2017
Table Global Gastric Cancer Drugs Revenue Forecast by Application (2018-2023)
Figure Global Gastric Cancer Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Gastric Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Gastric Cancer Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Gastric Cancer Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Europe Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure South America Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Gastric Cancer Drugs Revenue Market Forecast (2018-2023)
